clinical trials articles ↓

The Clinical Trial register is showing details for the bio-availabilty trial for COL-118/Sansrosa. This Phase 2 trial aims to compare the amount of the active ingredient that is bio-available when the newly formulated gel is used on rosacea skin, and when used as eye drops.

This announcement appears to be the extra trial asked for by the FDA who are concerned that …

In November 2006 I blogged about taking part in some research at Murdoch University investigating the relationship between stress and the flushing of rosacea. Recently the researcher, Daphne Su, has thanked the trial participants by circulating a summary document. The research has been written up as a thesis so this summary was a short description of some the …

Schlesinger Associates are looking for rosacea patients on Friday June 13 2008, to attend an interview for an hour at their Galleria Area location in Houston TX. Their address is 1455 West Loop South, Suite 500. …

A seemingly new topical treatment for rosacea is being trialled by Dow Pharmaceutical Sciences. The product is being evaluated firstly for the number of inflammatory lesions and global severity, and secondly for redness. This, along with the trial lasting 12 weeks, and the large size of the trial leads me to guess that IDP-115 is a metronidazole or azelaic acid variant.

Google hasn’t found any clues …

Laura Kopec from Kopec Naturals is offering free 1 oz samples of their Rosacea Relief product.

According to their web site, Rosacea Relief contains, “Proprietary blend of Barbadensis vulgaris (aloe vera), Hamamelis virginiana (witch hazel), Melaleuca alternifolia (tea tree) oil, and other natural ingredients.”

See her post at the Rosacea Support Forum - Free 1 oz Sample of Rosacea Relief for more information.
In a special …